Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001246 · ClinicalTrials.gov registry record
Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers
A clinical trial of Schizophrenia and Attention Deficit Hyperactivity Disorder, sponsored by National Institute of Mental Health (NIMH).
- Active
- Registry status
- 4,274
- Enrollment target
- 1
- Study location
NCT00001246: Active study of Schizophrenia and Attention Deficit Hyperactivity Disorder, sponsored by National Institute of Mental Health (NIMH).
NCT00001246 is a study of Schizophrenia and Attention Deficit Hyperactivity Disorder that is active but no longer recruiting, run by National Institute of Mental Health (NIMH). The registered enrollment target is 4,274 participants, above the 205-participant average among 315 other Schizophrenia trials with a reported enrollment target (1985% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001246, a study of Schizophrenia and Attention Deficit Hyperactivity Disorder, is active but no longer recruiting, sponsored by National Institute of Mental Health (NIMH).
- ACTIVE NOT RECRUITING
- Registry status
- 4,274 participants
- Enrollment target
- 1
- Study location
Study Summary
Magnetic Resonance Imaging (MRI) unlike X-rays and CT-scans does not use radiation to create a picture. MRI use as the name implies, magnetism to create pictures with excellent anatomical resolution. Functional MRIs are diagnostic tests that allow doctors to not only view anatomy, but physiology and function. It is for these reasons that MRIs are excellent methods for studying the brain. In this study, researchers will use MRI to assess brain anatomy and function in X and Y chromosome variation, healthy volunteers, and patients with a variety of childhood onset psychiatric disorders. The disorders include attention deficit disorder, autism, congenital adrenal hyperplasia, childhood-onset schizophrenia, dyslexia, obsessive compulsive disorder, Sydenham's chorea, and Tourette's syndrome. Results of the MRIs showing the anatomy of the brain and brain function will be compared across age, sex (gender), and diagnostic groups. Correlations between brain and behavioral measures will be examined for normal and clinical populations.
Primary Outcome
Volumetric MRI Data
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,274 participants |
| Start Date | 1990-06-19 |
What the registry record for NCT00001246 still lists
NCT00001246 is an observational study that tracks outcomes without assigning an intervention. Its 4,274 participants enrollment target places it among the larger protocols in the corpus, above the 205-participant average among 315 other Schizophrenia trials with a reported enrollment target (1985% higher).
The record links to 3 conditions, with Schizophrenia appearing as the primary indexed condition, and to 0 interventions.
NCT00001246 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00001246 about?
NCT00001246 is a clinical study titled "Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers". Magnetic Resonance Imaging (MRI) unlike X-rays and CT-scans does not use radiation to create a picture. MRI use as the name implies, magnetism to create pictures with excellent anatomical resolution. Functional MRIs are diagnostic tests that allow doctors to not only view anatomy, but physiology and...
What is the current status of trial NCT00001246?
This trial is currently active not recruiting. The enrollment target is 4,274 participants. The study started on 1990-06-19.
What conditions does trial NCT00001246 study?
This clinical trial studies the following conditions: Schizophrenia, Attention Deficit Hyperactivity Disorder, Attention Deficit Disorder With Hyperactivity.
Who is sponsoring clinical trial NCT00001246?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001246 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00001246's enrollment target sits among peer trials
4,274 2nd of 315 the highest of 315 other Schizophrenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Tolerability of MDMA in Schizophrenia
RECRUITING · Phase 1
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
RECRUITING · Phase 4
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05543616 · 4,292 participants · Phase 2
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
- NCT05774951 · 4,300 participants · Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
- NCT06492616 · 4,220 participants · Phase 3
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- NCT05910567 · 4,346 participants · NA
A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI